Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
33 Cards in this Set
- Front
- Back
Atorvastatin (Lipitor)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
Fluvastatin (Lescol)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
Lovastatin (Mevacor)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
Pravastatin (Pravachol)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
Rosuvastatin (Crestor)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
Simvastatin (Zocor)
|
HMG-CoA Reductase Inhibitors (statins)
|
|
HMG-CoA Reductase Inhibitors (statins) effects
|
decrease LDL (low density lipoprotein)
increase HDL (high density lipoprotein) decrease TG (triglycerides) -block cholesterol synthesis -anti inflammatory & anti thrombotic |
|
HMG-CoA Reductase Inhibitors (statins) considerations
|
-freq initial therapy for signif elevated cholesterol & LDL levels
-myopathy adverse effect -monitor hepatic function -contraindicated for liver disease |
|
Niacin-extended release (Niaspan)
|
Nicotinic Acids
|
|
Niacin-intermediate release (Niacor)
|
Nicotinic Acids
|
|
Niacin-sustained release (Slo-Niacin)
|
Nicotinic Acids
|
|
Nicotinic Acids effects
|
decrease LDL
increase HDL decrease TG decrease lipoprotein synthesis |
|
Nicotinic Acids used for
|
-may be used minimally for elevated cholesterol & LDL levels, or as an adjunct to a statin when lipid goal not achieved & TG levels are elevated
|
|
Nicotinic Acids side effects
|
flushing, hyperglycemia
hyperuricemia (gout), upper GI distress heptoxicity |
|
Nicotinic Acids other considerations
|
monitor hepatic function
containdicted in gout & liver failure dose needs to be titrated weekly to achieve therapeutic dosage |
|
Fenofibrate (TriCor)
|
Fibric Acids (fibrates)
|
|
Gemfibrozil (Lopid)
|
Fibric Acids (fibrates)
|
|
Fibric Acids (fibrates) effects
|
increase HDL
decrease TG decrease cholesterol synthesis |
|
Fibric Acids (fibrates) side effects
|
dyspepsia, gallstones, myopathy
|
|
Fibric Acids (fibrates) other considerations
|
-contraindicted in severe renal & liver disease
-have potential to increase LDL, may be used in pts w TG levels > 400mL/dL -use w caution w pts also taking a statin |
|
Cholestyramine (Questran)
|
Bile Acid Sequestrants
|
|
Colestipol (Colestid)
|
Bile Acid Sequestrants
|
|
Bile Acid Sequestrants effects
|
decrease LDL
slight increase HDL bind cholesterol & increase its breakdown |
|
Bile Acid Sequestrants use
|
most often used as adjunct therapy when statins alone not effective in controlling lipid levels & TG levels < 200mg/dL
|
|
Bile Acid Sequestrants side effects
|
GI distress
constipation decreased absorption of other drugs |
|
Ezetimibe (Zetia)
|
Cholesterol Absorption Inhibitor
|
|
Cholesterol Absorption Inhibitor effects
|
decrease LDL
increase HDL decrease TG |
|
Cholesterol Absorption Inhibitor considerations
|
-better tolerated than bile acid seq
-may be used in combination w other agents such as statins |
|
Cholesterol Absorption Inhibitor side effects
|
back pain, arthralgia (joint pain), & abdominal pain
|
|
Fish oil capsules
|
Omega-3-Acid-Ethyl Esters
|
|
Omega-3-Acid-Ethyl Esters effects
|
decrease TG
|
|
Omega-3-Acid-Ethyl Esters considerations
|
-may be used alone or in combination w other agents
|
|
Omega-3-Acid-Ethyl Esters side effects
|
taste perversion, rash, flu, back pain
|